CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
The expanded panel is being evaluated at the Bichat-Claude Bernard Hospital in Paris. “After more than a year of experience using the existing QIAstat-Dx Respiratory Panel to evaluate patients coming into our emergency department with respiratory syndromes, we are evaluating the new panel with SARS-CoV-2 against RT-PCR testing using WHO-recommended protocols,” Benoit Visseaux, PhD, associate professor of virology at Bichat-Claude Bernard Hospital, said in a Qiagen press release. “The QIAstat-Dx solution can provide results in about one hour, with high sensitivity and specificity and minimal hands-on time for hospital or laboratory personnel.”
Pages: 1 2